Cargando…

Nivolumab and Hypofractionated Radiotherapy in Patients With Advanced Lung Cancer: ABSCOPAL-1 Clinical Trial

BACKGROUND: More clinical practice need to be performed to verify the toxicity of the hypofractionated radiotherapy (HFRT) combined with PD-1 blockade in lung cancer. This phase I study aimed to investigate the safety and efficacy of nivolumab combined with HFRT in patients with progressive advanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Hua, Pang, Haowen, Shi, Xiangxiang, Ren, Peirong, Huang, Shangke, Yu, Hong, Wu, Jingbo, Lin, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100893/ https://www.ncbi.nlm.nih.gov/pubmed/33968760 http://dx.doi.org/10.3389/fonc.2021.657024

Ejemplares similares

Hypofractionated (192)Ir source stereotactic ablative brachytherapy with coplanar template assistance in the primary treatment of peripheral lung cancer
por: Pang, Haowen, et al.
Publicado: (2019)

Enhancing the Bystander and Abscopal Effects to Improve Radiotherapy Outcomes
por: Farias, Virgínea de Araújo, et al.
Publicado: (2020)

Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity
por: Lai, Jin-Zhi, et al.
Publicado: (2021)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Abscopal Effect of Radiotherapy in Imatinib-resistant Dermatofibrosarcoma Protuberans
por: Agyeman, Mervin B, et al.
Publicado: (2019)

Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants
por: Moreau, Michele, et al.
Publicado: (2018)

Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia
por: Chi, Mau-Shin, et al.
Publicado: (2020)

Abscopal effect in metastatic breast cancer treated with stereotactic body radiotherapy in the absence of immunotherapy
por: Kim, Jae Sik, et al.
Publicado: (2023)

Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report
por: Endo, Masashi, et al.
Publicado: (2023)

Abscopal Effect of Radiotherapy in the Immunotherapy Era: Systematic Review of Reported Cases
por: Dagoglu, Nergiz, et al.
Publicado: (2019)

Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers
por: Abdo, Joe, et al.
Publicado: (2018)

Abscopal effect observed in visceral and osseous metastases after liver SBRT in combination with nivolumab and relatlimab for sinonasal mucosal melanoma—a case report
por: Cerbon, Danielle, et al.
Publicado: (2023)

A Case of Complete Abscopal Response in High-Grade Pleiomorphic Sarcoma Treated with Radiotherapy Alone
por: Orton, Andrew, et al.
Publicado: (2016)

Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma
por: Brenneman, Randall J., et al.
Publicado: (2019)

Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience
por: Musunuru, Hima Bindu, et al.
Publicado: (2014)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
por: Laursen, Michael, et al.
Publicado: (2018)

Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa
por: Swanson, William, et al.
Publicado: (2021)

Hypofractionated Radiotherapy for Palliation of Main Portal Vein Tumor Thrombosis
por: Fang, Fang, et al.
Publicado: (2022)

Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer
por: Britschgi, Christian, et al.
Publicado: (2018)

Boosting Abscopal Response to Radiotherapy with Sargramostim: A Review of Data and Ongoing Studies
por: Leary, Robyn, et al.
Publicado: (2019)

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma
por: Kazandjian, Dickran, et al.
Publicado: (2021)

Robustness of hypofractionated breast radiotherapy after breast-conserving surgery with free breathing
por: Chen, Kunzhi, et al.
Publicado: (2023)

Real-World Practice of Hypofractionated Radiotherapy in Patients With Invasive Breast Cancer
por: Chen, Fang, et al.
Publicado: (2022)

Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT
por: Shen, Junyue, et al.
Publicado: (2021)

Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer
por: Banfill, Kathryn, et al.
Publicado: (2022)

Potentiation of the Abscopal Effect by Modulated Electro-Hyperthermia in Locally Advanced Cervical Cancer Patients
por: Minnaar, Carrie Anne, et al.
Publicado: (2020)

Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance
por: Hafeez, Shaista, et al.
Publicado: (2020)

Effectiveness of hypofractionated and normofractionated radiotherapy in a triple‐negative breast cancer model
por: Grosche, Sinja, et al.
Publicado: (2022)

Moderately Hypofractionated Radiotherapy Alone for Stage I-IIB Non-small Cell Lung Cancer
por: Hughes, Ryan T, et al.
Publicado: (2019)

Predictive value of (18)F-FDG PET/CT for evaluating the response to hypofractionated radiotherapy combined with PD-1 blockade in non-small cell lung cancer
por: Tang, Shan, et al.
Publicado: (2023)

Phase II Trial of Pure Hypofractionated Radiotherapy in the Treatment of Localized Carcinoma of the Prostate
por: Gopaul, Darin, et al.
Publicado: (2018)

Short Course Hypofractionated Radiotherapy for Frail or Elderly Patients With Meningioma
por: Sarhan, Nasim, et al.
Publicado: (2020)

Systemic benefit of radiation therapy via abscopal effect
por: Craig, Daniel J., et al.
Publicado: (2022)

Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme
por: Greer, Liana, et al.
Publicado: (2017)

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
por: Arpa, Donatella, et al.
Publicado: (2021)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
por: He, Jiaoxue, et al.
Publicado: (2023)

First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma
por: Barsky, Andrew R, et al.
Publicado: (2019)

Possible abscopal effect after discontinuation of nivolumab in metastatic renal cell carcinoma
por: Nakajima, Nobuyuki, et al.
Publicado: (2020)

Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer
por: Yang, Szu-Chun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5qtqed3q5bpvr5pgca82castgn